NGM BIOPHARMACEUTICALS INC (19) | Business Operations (4)

Browse by Subcategory

Sales Agreements (4)

Recent Contracts

Amendment No. 7 on December 22, 2020 to Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014 (Filed With SEC on March 15, 2021)
Amendment No. 8 on February 10, 2021 to Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014 (Filed With SEC on March 15, 2021)
Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014, as amended by Amendment No. 1 on July 28, 2015,... (Filed With SEC on April 1, 2019)
Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014, as amended by Amendment No. 1 on July 28, 2015,... (Filed With SEC on March 25, 2019)